{"name":"EMS","slug":"ems","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":594768,"revenueGrowth":-89.9,"grossMargin":0,"rdSpend":21636,"netIncome":-3607145,"cash":805500,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":18,"colorKey":"immunology","drugs":[{"name":"PIEMONTE","genericName":"PIEMONTE","slug":"piemonte","indication":"Other","status":"phase_3"},{"name":"Afrin","genericName":"Afrin","slug":"afrin","indication":"Other","status":"marketed"},{"name":"Atenas","genericName":"Atenas","slug":"atenas","indication":"Other","status":"discontinued"},{"name":"BALI association","genericName":"BALI association","slug":"bali-association","indication":"Other","status":"phase_3"},{"name":"CDE100 association","genericName":"CDE100 association","slug":"cde100-association","indication":"Other","status":"phase_3"},{"name":"DEC103","genericName":"DEC103","slug":"dec103","indication":"Other","status":"marketed"},{"name":"DEP114","genericName":"DEP114","slug":"dep114","indication":"Other","status":"phase_3"},{"name":"Egito","genericName":"Egito","slug":"egito","indication":"Other","status":"discontinued"},{"name":"MADALENA ASSOCIATION","genericName":"MADALENA ASSOCIATION","slug":"madalena-association","indication":"Other","status":"phase_3"},{"name":"Naridrin","genericName":"Naridrin","slug":"naridrin","indication":"Other","status":"phase_3"},{"name":"Neosil","genericName":"Neosil","slug":"neosil","indication":"Other","status":"marketed"},{"name":"Neosil complete","genericName":"Neosil complete","slug":"neosil-complete","indication":"Other","status":"marketed"},{"name":"Omnic Ocas","genericName":"Omnic Ocas","slug":"omnic-ocas","indication":"Benign prostatic hyperplasia with lower urinary tract symptoms","status":"phase_3"},{"name":"Pantogar","genericName":"Pantogar","slug":"pantogar","indication":"Other","status":"marketed"},{"name":"Prograf","genericName":"Prograf","slug":"prograf","indication":"Other","status":"marketed"},{"name":"Tanzânia association","genericName":"Tanzânia association","slug":"tanz-nia-association","indication":"Other","status":"phase_3"},{"name":"Toronto association","genericName":"Toronto association","slug":"toronto-association","indication":"Various conditions","status":"phase_3"},{"name":"Zolpidem Hemitartrate","genericName":"Zolpidem Hemitartrate","slug":"zolpidem-hemitartrate","indication":"Insomnia (short-term treatment of sleep initiation difficulty)","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":7,"colorKey":"oncology","drugs":[{"name":"DIT112","genericName":"DIT112","slug":"dit112","indication":"Type 2 diabetes","status":"phase_3"},{"name":"BERLIM 25/10 association","genericName":"BERLIM 25/10 association","slug":"berlim-25-10-association","indication":"Essential hypertension","status":"phase_3"},{"name":"BERLIM 25/20 ASSOCIATION","genericName":"BERLIM 25/20 ASSOCIATION","slug":"berlim-25-20-association","indication":"Essential hypertension","status":"phase_3"},{"name":"Bramicar HCT","genericName":"Bramicar HCT","slug":"bramicar-hct","indication":"Hypertension with metabolic dysfunction","status":"phase_3"},{"name":"Flamboyant 125/12","genericName":"Flamboyant 125/12","slug":"flamboyant-125-12","indication":"Hypertension","status":"phase_3"},{"name":"Flamboyant 200/12","genericName":"Flamboyant 200/12","slug":"flamboyant-200-12","indication":"Hypertension","status":"phase_3"},{"name":"Micardis Anlo","genericName":"Micardis Anlo","slug":"micardis-anlo","indication":"Hypertension","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":7,"colorKey":"neuroscience","drugs":[{"name":"Apevitin BC","genericName":"Apevitin BC","slug":"apevitin-bc","indication":"B vitamin deficiency supplementation","status":"phase_3"},{"name":"Bayer Acarbose","genericName":"Bayer Acarbose","slug":"bayer-acarbose","indication":"Type 2 diabetes mellitus","status":"phase_3"},{"name":"DEH113","genericName":"DEH113","slug":"deh113","indication":"Type 2 diabetes","status":"phase_3"},{"name":"DTT106","genericName":"DTT106","slug":"dtt106","indication":"Type 2 diabetes","status":"phase_3"},{"name":"EMS Acarbose","genericName":"EMS Acarbose","slug":"ems-acarbose","indication":"Type 2 diabetes mellitus","status":"phase_3"},{"name":"OMA102","genericName":"OMA102","slug":"oma102","indication":"Type 2 diabetes","status":"phase_3"},{"name":"Tradjenta","genericName":"Tradjenta","slug":"tradjenta","indication":"Diabetes mellitus type 2","status":"discontinued"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"rare","drugs":[{"name":"Buscopan® Composto association","genericName":"Buscopan® Composto association","slug":"buscopan-composto-association","indication":"Abdominal pain and cramping associated with gastrointestinal spasms","status":"phase_3"},{"name":"Cyclobenzaprine with caffeine","genericName":"Cyclobenzaprine with caffeine","slug":"cyclobenzaprine-with-caffeine","indication":"Acute muscle spasm and musculoskeletal pain","status":"phase_3"},{"name":"Nimesulide + Pantoprazole","genericName":"Nimesulide + Pantoprazole","slug":"nimesulide-pantoprazole","indication":"Acute pain and inflammation with gastric protection","status":"phase_3"},{"name":"ketoprofen and cyclobenzaprine association","genericName":"ketoprofen and cyclobenzaprine association","slug":"ketoprofen-and-cyclobenzaprine-association","indication":"Relief of pain and inflammation","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"metabolic","drugs":[{"name":"Cipros 10 association","genericName":"Cipros 10 association","slug":"cipros-10-association","indication":"Bacterial infections (specific indications not clearly defined in available data)","status":"phase_3"},{"name":"Cipros 20 association","genericName":"Cipros 20 association","slug":"cipros-20-association","indication":"Bacterial infections (specific indications not clearly defined in available literature)","status":"phase_3"},{"name":"Methenamine and Methylthioninium chloride","genericName":"Methenamine and Methylthioninium chloride","slug":"methenamine-and-methylthioninium-chloride","indication":"Urinary tract infections (prophylaxis and treatment)","status":"phase_3"},{"name":"betamethasone + gentamicin + tolnaftato + cleoquinol","genericName":"betamethasone + gentamicin + tolnaftato + cleoquinol","slug":"betamethasone-gentamicin-tolnaftato-cleoquinol","indication":"skin infections","status":"phase_3"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"cardiovascular","drugs":[{"name":"Praga formulation","genericName":"Praga formulation","slug":"praga-formulation","indication":"Non-small cell lung cancer, PD-L1 positive","status":"phase_3"},{"name":"MAZ-101association","genericName":"MAZ-101association","slug":"maz-101association","indication":"Non-small cell lung cancer, PD-L1 positive","status":"phase_3"},{"name":"TCA108","genericName":"TCA108","slug":"tca108","indication":"Advanced solid tumors with PI3K pathway alterations","status":"phase_3"}]},{"name":"Ophthalmology","slug":"ophthalmology","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"infectious","drugs":[{"name":"BREMEN eye drops","genericName":"BREMEN eye drops","slug":"bremen-eye-drops","indication":"Dry eye disease / Keratoconjunctivitis sicca","status":"phase_3"},{"name":"Naphazoline hydrocloride + Pheniramine Maleate + Panthenol","genericName":"Naphazoline hydrocloride + Pheniramine Maleate + Panthenol","slug":"naphazoline-hydrocloride-pheniramine-maleate-panthenol","indication":"Redness and congestion of the eyes due to allergic rhinitis or other conditions","status":"phase_3"},{"name":"naphazoline hydrocloride","genericName":"naphazoline hydrocloride","slug":"naphazoline-hydrocloride","indication":"Ocular redness and congestion associated with minor eye irritation","status":"phase_3"}]},{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"respiratory","drugs":[{"name":"Budesonide / Formoterol 400/12","genericName":"Budesonide / Formoterol 400/12","slug":"budesonide-formoterol-400-12","indication":"Asthma maintenance therapy","status":"phase_3"},{"name":"Budesonide/formoterol 200/6","genericName":"Budesonide/formoterol 200/6","slug":"budesonide-formoterol-200-6","indication":"Asthma maintenance therapy","status":"phase_3"},{"name":"Syrup of guaifenesin","genericName":"Syrup of guaifenesin","slug":"syrup-of-guaifenesin","indication":"Productive cough associated with common cold, bronchitis, and other respiratory conditions","status":"phase_3"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"ophthalmology","drugs":[{"name":"LID104","genericName":"LID104","slug":"lid104","indication":"Major depressive disorder","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"dermatology","drugs":[{"name":"Vitamin B Complex + Vitamin C","genericName":"Vitamin B Complex + Vitamin C","slug":"vitamin-b-complex-vitamin-c","indication":"Vitamin B and C deficiency prevention and treatment","status":"marketed"}]}],"pipeline":[{"name":"DIT112","genericName":"DIT112","slug":"dit112","phase":"phase_3","mechanism":"DIT112 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes","Heart failure"],"catalyst":""},{"name":"PIEMONTE","genericName":"PIEMONTE","slug":"piemonte","phase":"phase_3","mechanism":"Piemonte's mechanism of action is not publicly available.","indications":[],"catalyst":""},{"name":"Praga formulation","genericName":"Praga formulation","slug":"praga-formulation","phase":"phase_3","mechanism":"Praga formulation is a drug that works by targeting the PD-1/PD-L1 pathway to modulate the immune system.","indications":["Non-small cell lung cancer, PD-L1 positive","Head and neck squamous cell carcinoma"],"catalyst":""},{"name":"Afrin","genericName":"Afrin","slug":"afrin","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Apevitin BC","genericName":"Apevitin BC","slug":"apevitin-bc","phase":"phase_3","mechanism":"Apevitin BC is a B-complex vitamin formulation that provides essential B vitamins to support metabolic function and energy production.","indications":["B vitamin deficiency supplementation","Metabolic support and energy production"],"catalyst":""},{"name":"Atenas","genericName":"Atenas","slug":"atenas","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"BALI association","genericName":"BALI association","slug":"bali-association","phase":"phase_3","mechanism":"BALI is a fixed-dose combination association designed to treat a specific therapeutic indication through synergistic action of its component drugs.","indications":[],"catalyst":""},{"name":"BERLIM 25/10 association","genericName":"BERLIM 25/10 association","slug":"berlim-25-10-association","phase":"phase_3","mechanism":"BERLIM 25/10 is a fixed-dose combination of losartan (angiotensin II receptor antagonist) and hydrochlorothiazide (thiazide diuretic) that reduces blood pressure through dual antihypertensive pathways.","indications":["Essential hypertension"],"catalyst":""},{"name":"BERLIM 25/20 ASSOCIATION","genericName":"BERLIM 25/20 ASSOCIATION","slug":"berlim-25-20-association","phase":"phase_3","mechanism":"BERLIM 25/20 is a fixed-dose combination of losartan (angiotensin II receptor antagonist) and hydrochlorothiazide (thiazide diuretic) that reduces blood pressure through dual antihypertensive pathways.","indications":["Essential hypertension"],"catalyst":""},{"name":"BREMEN eye drops","genericName":"BREMEN eye drops","slug":"bremen-eye-drops","phase":"phase_3","mechanism":"BREMEN eye drops is a topical ophthalmic formulation designed to treat dry eye disease by lubricating and protecting the ocular surface.","indications":["Dry eye disease / Keratoconjunctivitis sicca"],"catalyst":""},{"name":"Bayer Acarbose","genericName":"Bayer Acarbose","slug":"bayer-acarbose","phase":"phase_3","mechanism":"Acarbose inhibits intestinal alpha-glucosidase enzymes to slow the digestion and absorption of carbohydrates, reducing postprandial blood glucose spikes.","indications":["Type 2 diabetes mellitus","Postprandial hyperglycemia in type 2 diabetes"],"catalyst":""},{"name":"Bramicar HCT","genericName":"Bramicar HCT","slug":"bramicar-hct","phase":"phase_3","mechanism":"Bramicar HCT is a fixed-dose combination of bromocriptine and hydrochlorothiazide that reduces dopamine antagonism in the hypothalamus while providing diuretic and antihypertensive effects.","indications":["Hypertension with metabolic dysfunction"],"catalyst":""},{"name":"Budesonide / Formoterol 400/12","genericName":"Budesonide / Formoterol 400/12","slug":"budesonide-formoterol-400-12","phase":"phase_3","mechanism":"Budesonide reduces airway inflammation via glucocorticoid receptor activation, while formoterol dilates airways by stimulating beta-2 adrenergic receptors.","indications":["Asthma maintenance therapy","Chronic obstructive pulmonary disease (COPD) maintenance therapy"],"catalyst":""},{"name":"Budesonide/formoterol 200/6","genericName":"Budesonide/formoterol 200/6","slug":"budesonide-formoterol-200-6","phase":"phase_3","mechanism":"Budesonide/formoterol combines an inhaled corticosteroid that reduces airway inflammation with a long-acting beta-2 agonist that relaxes airway smooth muscle.","indications":["Asthma maintenance therapy","Chronic obstructive pulmonary disease (COPD) maintenance therapy"],"catalyst":""},{"name":"Buscopan® Composto association","genericName":"Buscopan® Composto association","slug":"buscopan-composto-association","phase":"phase_3","mechanism":"Buscopan Composto combines hyoscine butylbromide (an anticholinergic agent) with paracetamol to relieve abdominal pain and cramping while reducing fever.","indications":["Abdominal pain and cramping associated with gastrointestinal spasms","Symptomatic relief of functional gastrointestinal disorders"],"catalyst":""},{"name":"CDE100 association","genericName":"CDE100 association","slug":"cde100-association","phase":"phase_3","mechanism":"CDE100 is a fixed-dose combination drug developed by EMS, currently in phase 3 clinical trials.","indications":[],"catalyst":""},{"name":"Cipros 10 association","genericName":"Cipros 10 association","slug":"cipros-10-association","phase":"phase_3","mechanism":"Cipros 10 association is a fixed-dose combination of ciprofloxacin and an additional agent designed to enhance antimicrobial efficacy.","indications":["Bacterial infections (specific indications not clearly defined in available data)"],"catalyst":""},{"name":"Cipros 20 association","genericName":"Cipros 20 association","slug":"cipros-20-association","phase":"phase_3","mechanism":"Cipros 20 association is a fixed-dose combination of ciprofloxacin and an additional agent designed to enhance antimicrobial efficacy.","indications":["Bacterial infections (specific indications not clearly defined in available literature)"],"catalyst":""},{"name":"Cyclobenzaprine with caffeine","genericName":"Cyclobenzaprine with caffeine","slug":"cyclobenzaprine-with-caffeine","phase":"phase_3","mechanism":"Cyclobenzaprine is a muscle relaxant that reduces muscle tension through central nervous system depression, while caffeine is a stimulant that counteracts sedation and enhances alertness.","indications":["Acute muscle spasm and musculoskeletal pain"],"catalyst":""},{"name":"DEC103","genericName":"DEC103","slug":"dec103","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"DEH113","genericName":"DEH113","slug":"deh113","phase":"phase_3","mechanism":"DEH113 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"DEP114","genericName":"DEP114","slug":"dep114","phase":"phase_3","mechanism":"DEP114 is an investigational immunotherapeutic agent designed to modulate immune responses, though its precise mechanism remains proprietary.","indications":[],"catalyst":""},{"name":"DTT106","genericName":"DTT106","slug":"dtt106","phase":"phase_3","mechanism":"DTT106 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"EMS Acarbose","genericName":"EMS Acarbose","slug":"ems-acarbose","phase":"phase_3","mechanism":"Acarbose inhibits intestinal alpha-glucosidase enzymes to slow carbohydrate digestion and reduce postprandial glucose spikes.","indications":["Type 2 diabetes mellitus"],"catalyst":""},{"name":"Egito","genericName":"Egito","slug":"egito","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Flamboyant 125/12","genericName":"Flamboyant 125/12","slug":"flamboyant-125-12","phase":"phase_3","mechanism":"Flamboyant 125/12 is a fixed-dose combination of a calcium channel blocker and a beta blocker.","indications":["Hypertension"],"catalyst":""},{"name":"Flamboyant 200/12","genericName":"Flamboyant 200/12","slug":"flamboyant-200-12","phase":"phase_3","mechanism":"Flamboyant 200/12 is a fixed-dose combination of a calcium channel blocker and a beta blocker.","indications":["Hypertension"],"catalyst":""},{"name":"LID104","genericName":"LID104","slug":"lid104","phase":"phase_3","mechanism":"LID104 is a small molecule that targets the serotonin receptor.","indications":["Major depressive disorder"],"catalyst":""},{"name":"MADALENA ASSOCIATION","genericName":"MADALENA ASSOCIATION","slug":"madalena-association","phase":"phase_3","mechanism":"MADALENA is a fixed-dose combination product developed by EMS, likely containing multiple active pharmaceutical ingredients to address a specific therapeutic indication.","indications":[],"catalyst":""},{"name":"MAZ-101association","genericName":"MAZ-101association","slug":"maz-101association","phase":"phase_3","mechanism":"MAZ-101association is a drug that targets the PD-1/PD-L1 pathway to modulate the immune response.","indications":["Non-small cell lung cancer, PD-L1 positive","Head and neck squamous cell carcinoma"],"catalyst":""},{"name":"Methenamine and Methylthioninium chloride","genericName":"Methenamine and Methylthioninium chloride","slug":"methenamine-and-methylthioninium-chloride","phase":"phase_3","mechanism":"Methenamine releases formaldehyde in acidic urine to provide antimicrobial activity, while methylthioninium chloride (methylene blue) acts as an antimicrobial agent and urinary antiseptic.","indications":["Urinary tract infections (prophylaxis and treatment)","Recurrent urinary tract infections"],"catalyst":""},{"name":"Micardis Anlo","genericName":"Micardis Anlo","slug":"micardis-anlo","phase":"phase_3","mechanism":"Micardis Anlo is an angiotensin II receptor antagonist that blocks the action of angiotensin II, a potent vasoconstrictor, to lower blood pressure.","indications":["Hypertension"],"catalyst":""},{"name":"Naphazoline hydrocloride + Pheniramine Maleate + Panthenol","genericName":"Naphazoline hydrocloride + Pheniramine Maleate + Panthenol","slug":"naphazoline-hydrocloride-pheniramine-maleate-panthenol","phase":"phase_3","mechanism":"Naphazoline hydrochloride is a sympathomimetic agent that acts as an alpha-adrenergic agonist, while pheniramine maleate is an antihistamine that exerts its effects by competitively inhibiting the action of histamine at the H1 receptor. Panthenol, a form of vitamin B5, has moisturizing and soothing properties.","indications":["Redness and congestion of the eyes due to allergic rhinitis or other conditions"],"catalyst":""},{"name":"Naridrin","genericName":"Naridrin","slug":"naridrin","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Neosil","genericName":"Neosil","slug":"neosil","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Neosil complete","genericName":"Neosil complete","slug":"neosil-complete","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Nimesulide + Pantoprazole","genericName":"Nimesulide + Pantoprazole","slug":"nimesulide-pantoprazole","phase":"phase_3","mechanism":"Nimesulide inhibits cyclooxygenase (COX) enzymes to reduce inflammation and pain, while pantoprazole suppresses gastric acid production to protect the stomach lining.","indications":["Acute pain and inflammation with gastric protection","Musculoskeletal pain conditions requiring NSAID therapy with reduced GI risk"],"catalyst":""},{"name":"OMA102","genericName":"OMA102","slug":"oma102","phase":"phase_3","mechanism":"OMA102 is a small molecule that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"Omnic Ocas","genericName":"Omnic Ocas","slug":"omnic-ocas","phase":"phase_3","mechanism":"Omnic Ocas is a once-daily oral formulation of tamsulosin that selectively blocks alpha-1A adrenergic receptors in the prostate and bladder neck to relieve urinary obstruction.","indications":["Benign prostatic hyperplasia with lower urinary tract symptoms"],"catalyst":""},{"name":"Pantogar","genericName":"Pantogar","slug":"pantogar","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Prograf","genericName":"Prograf","slug":"prograf","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Syrup of guaifenesin","genericName":"Syrup of guaifenesin","slug":"syrup-of-guaifenesin","phase":"phase_3","mechanism":"Guaifenesin reduces mucus viscosity and promotes clearance of respiratory secretions by increasing hydration of mucus in the airways.","indications":["Productive cough associated with common cold, bronchitis, and other respiratory conditions"],"catalyst":""},{"name":"TCA108","genericName":"TCA108","slug":"tca108","phase":"phase_3","mechanism":"TCA108 is a small molecule that targets the PI3K/AKT/mTOR pathway.","indications":["Advanced solid tumors with PI3K pathway alterations"],"catalyst":""},{"name":"Tanzânia association","genericName":"Tanzânia association","slug":"tanz-nia-association","phase":"phase_3","mechanism":"Tanzânia association is not a known drug, but it may be related to a Tanzanian region or a hypothetical drug name.","indications":[],"catalyst":""},{"name":"Toronto association","genericName":"Toronto association","slug":"toronto-association","phase":"phase_3","mechanism":"Toronto association drug is used to treat various conditions by modulating the immune system.","indications":["Various conditions"],"catalyst":""},{"name":"Tradjenta","genericName":"Tradjenta","slug":"tradjenta","phase":"discontinued","mechanism":"Dipeptidyl peptidase 9, Prolyl endopeptidase FAP, Dipeptidyl peptidase 4","indications":["Diabetes mellitus type 2"],"catalyst":""},{"name":"Vitamin B Complex + Vitamin C","genericName":"Vitamin B Complex + Vitamin C","slug":"vitamin-b-complex-vitamin-c","phase":"marketed","mechanism":"Vitamin B Complex and Vitamin C work as essential micronutrient cofactors that support energy metabolism, immune function, and antioxidant defense.","indications":["Vitamin B and C deficiency prevention and treatment","Nutritional supplementation for general health and immune support"],"catalyst":""},{"name":"Zolpidem Hemitartrate","genericName":"Zolpidem Hemitartrate","slug":"zolpidem-hemitartrate","phase":"marketed","mechanism":"Zolpidem hemitartrate is a sedative-hypnotic that binds to GABA-A receptors in the brain to enhance inhibitory neurotransmission and promote sleep onset.","indications":["Insomnia (short-term treatment of sleep initiation difficulty)"],"catalyst":""},{"name":"betamethasone + gentamicin + tolnaftato + cleoquinol","genericName":"betamethasone + gentamicin + tolnaftato + cleoquinol","slug":"betamethasone-gentamicin-tolnaftato-cleoquinol","phase":"phase_3","mechanism":"Betamethasone is a corticosteroid that reduces inflammation, gentamicin is an antibiotic that kills bacteria, tolnaftate is an antifungal that inhibits fungal growth, and cleocinol is an antibiotic that inhibits bacterial cell wall synthesis.","indications":["skin infections","wound infections"],"catalyst":""},{"name":"ketoprofen and cyclobenzaprine association","genericName":"ketoprofen and cyclobenzaprine association","slug":"ketoprofen-and-cyclobenzaprine-association","phase":"phase_3","mechanism":"Ketoprofen is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase enzymes, reducing prostaglandin synthesis and inflammation, while cyclobenzaprine is a muscle relaxant that acts as a central nervous system depressant, affecting the brain's motor control centers.","indications":["Relief of pain and inflammation","Muscle spasms"],"catalyst":""},{"name":"naphazoline hydrocloride","genericName":"naphazoline hydrocloride","slug":"naphazoline-hydrocloride","phase":"phase_3","mechanism":"Naphazoline hydrochloride is an alpha-1 adrenergic agonist that causes vasoconstriction of blood vessels in the eye or nasal passages.","indications":["Ocular redness and congestion associated with minor eye irritation","Nasal congestion due to allergies or colds"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNcTZPSDZ6WVY0Z1BXbUR0bFFmRHgtSnZFb2o2X041RTljdWJqVDduakNKTjlaeXVGT2twUVBweGoydTRXSks4b1Qtb3NQcXY0c1NDalBvWlNVbDFnc2QzTDgzQnp3RnlDbFVIVlEwTnhoTGQ4cDRhYVppaXpSY0lyWW8zVGNCQnlzUXYzcXBlNnQ0U1JTeGVHRnJkcXZxblp4S2c?oc=5","date":"2026-03-10","type":"pipeline","source":"Global Banking & Finance Review®","summary":"EMS Eyes Global Expansion After $500M Sanofi Medley Acquisition - Global Banking & Finance Review®","headline":"EMS Eyes Global Expansion After $500M Sanofi Medley Acquisition - Global Banking & Finance Review®","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQUXl1Zmp3X2M3RGRzQUl2VUVYUkpZM1N4dTMyMUdhRWpJZXhRdmR1MVpVNi1qc21xMnktRWk4R3NKYnBSOFlReGNaTUhCSWFDdE1jelBiVFBJT3Yxb1pPR1JmREpWUVJOcE53MktXcnp3VTMzWmdmV2gxXzBGbmRtTTdMSDk4Y1k4T21Jb1J2U1FjcG1tX3p3T2EweXl4SUZ1Q0dnRDJ6V0N5bHZQamtwLXRLUHA?oc=5","date":"2026-03-06","type":"deal","source":"Fierce Pharma","summary":"Sanofi strikes deal with Brazil's EMS to sell generics manufacturer Medley - Fierce Pharma","headline":"Sanofi strikes deal with Brazil's EMS to sell generics manufacturer Medley","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE1WSDIxTlc5ajBVTTdfbXgxaXY1TnJzSUxRWkpsUUk3bkJxd1JoajF0eXc2ZDAtMVN0UXRfWE5KZ3VOYkpwRVlPZ1RFNllvWElUZXVRMFh0Vkd5bGVFRDJlRklhdVUtbHJGaGx6ZW4yVWZUS2FfeUNUTnlDaTNWdw?oc=5","date":"2026-03-06","type":"pipeline","source":"Seeking Alpha","summary":"Sanofi to sell Medley unit to Brazil’s EMS for more than $500M - Seeking Alpha","headline":"Sanofi to sell Medley unit to Brazil’s EMS for more than $500M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9RZnMxMEZNaC1UZWJEMVJ0dG9PU0xkalIxYjRESnZiRFdMa1pQbDJBMnJUb2Y4amZxaVZGeVFPZTd4NDQ2VjB4Mi1kc1VoYlRxQ1Nn?oc=5","date":"2026-03-06","type":"pipeline","source":"FirstWord Pharma","summary":"Biopharma bites: Zealand's stock sell-off, Solid's private raise and Sanofi's Medley sale - FirstWord Pharma","headline":"Biopharma bites: Zealand's stock sell-off, Solid's private raise and Sanofi's Medley sale","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-06","type":"deal","source":"Valor International","summary":"EMS outbids competitors with R$3.2bn deal for Medley - Valor International","headline":"EMS outbids competitors with R$3.2bn deal for Medley","sentiment":"neutral"},{"date":"2026-02-23","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: FORM 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-01","type":"pipeline","source":"Moneycontrol.com","summary":"Pharma, textile and EMS stocks lead gains after Budget announcements - Moneycontrol.com","headline":"Pharma, textile and EMS stocks lead gains after Budget announcements","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-29","type":"pipeline","source":"Valor International","summary":"Sun Pharma, EMS ready binding bids for Medley - Valor International","headline":"Sun Pharma, EMS ready binding bids for Medley","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxOWXpubG9hRlZxVXZnZEh2OWVlZWQ3RjhBSnAzTmhlZGNjOFMtcTJockcxbEdLTjRGMFJLLVJWaWZpVjhmVHdwLTVNckVLaDFlUWF6cXB5U2J1M0VONjRYRGNJbVVEVU1uakNsX1BFRkJhdHdoNWUyX3VLYnBqTVlUdUxJYUVmMk9MWkU3N1JBZnhxTWFfYnh6MTMwR1JUbDlGV3hGMTFmM3NHeWtFeXNYdXJZcklIYnFPQzcxOVRmTC0?oc=5","date":"2025-12-09","type":"pipeline","source":"NeoFeed","summary":"EMS debuts in the US with a slimming pen and enters the competition for a billion-dollar market - NeoFeed","headline":"EMS debuts in the US with a slimming pen and enters the competition for a billion-dollar market","sentiment":"neutral"},{"date":"2025-11-14","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: FORM 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2025-09-30","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: FORM 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2025-08-07","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxPSTRENE40SUdQQjRNenZHRTNKdGJTb3owZlJnYzZTdkJ2LUUzU2ZIM291S3FWUy1UWjl0MTN1QkMzWFI2dXhRU3FVdGJvYjhFRmZlbGlBeTNqUWdHcEZHV1hUNnBWUUxCXzZsQ2c5YUNKSEEyaXVIcWpfN3lzei1TbXctRldibElKc1NPMC04WUljWWxDNnlSWktmNTFpTHZQdkliS0RKRWpSMHFUM1hwS3RjUEtsMnZmQWtlcDRRaVNDbHgyZ0t3WS1KUXhla1lXZEFxVGF2QTBMY2dQS1dzQzF3?oc=5","date":"2025-07-08","type":"deal","source":"facebook.com","summary":"📌Stock of The Day Buy Syrma SGS: SL 606 Tgt 622, 628, 638 Positive report on EMS stocks by JP Morgan Initiated coverage with Target of 800 Buy Lupin Futures: SL 1900 Tgt 1948, 1972, 1998 Tariff on pha","headline":"📌Stock of The Day Buy Syrma SGS: SL 606 Tgt 622, 628, 638 Positive report on EMS stocks by JP Morgan Initiated coverage ","sentiment":"neutral"},{"date":"2025-06-24","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"date":"2025-05-16","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: FORM 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"}],"patents":[],"drugCount":51,"phaseCounts":{"phase_3":40,"marketed":8,"discontinued":3},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar","revenue":594768,"revenuePeriod":"2025-06-30","revenueHistory":[{"value":594768,"period":"2025-06-30"},{"value":5863935,"period":"2024-06-30"},{"value":0,"period":"2024-06-30"},{"value":3862849,"period":"2023-06-30"},{"value":3862849,"period":"2023-06-30"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":21636,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-3607145,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":805500,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}